Genophin

Genophin is a precision medicine biotechnology company headquartered in San Diego, California. The company utilizes a proprietary platform that integrates artificial intelligence with genomic data to discover novel therapeutic targets and develop personalized treatments. Genophin's research and development efforts are primarily directed toward oncology and rare diseases, where there is a significant unmet medical need. By applying advanced computational models to multi-omic datasets, the company seeks to enhance the efficiency and precision of the drug discovery process. Founded in 2020 by a team of experienced life science professionals, Genophin is currently in the pre-clinical stage of development.